clonixin has been researched along with Endotoxemia in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eades, SC; Fugler, LA; Keowen, ML; Koch, CE; Moore, RM | 1 |
Avci, GE; Bulbul, A; Elmas, M; Er, A; Tras, B; Uney, K; Yazar, E | 1 |
Badiei, K; Chalmeh, A; Nazifi, S; Pourjafar, M | 1 |
Elmas, M; Er Karabacak, A; Traş, B; Uney, K; Yazar, E | 1 |
Altunok, V; Elmas, M; Er, A; Uney, K; Yazar, E | 1 |
Gessert, ME; Scott, PR | 1 |
Baxter, G; Shuster, R; Traub-Dargatz, J | 1 |
Anders, B; Barton, MH; Baskett, A; Moore, JN; Norton, N | 1 |
8 other study(ies) available for clonixin and Endotoxemia
Article | Year |
---|---|
Plasma matrix metalloproteinase activity in horses after intravenous infusion of lipopolysaccharide and treatment with matrix metalloproteinase inhibitors.
Topics: Animals; Body Temperature; Clonixin; Doxycycline; Endotoxemia; Enzyme Induction; Enzyme Inhibitors; Female; Heart Rate; Horses; Lipopolysaccharides; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Oxytetracycline; Pentoxifylline; Random Allocation; Respiratory Rate | 2013 |
Effects of enrofloxacin, flunixin meglumine and dexamethasone on disseminated intravascular coagulation, cytokine levels and adenosine deaminase activity in endotoxaemia in rats.
Topics: Adenosine Deaminase; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Clonixin; Cytokines; Dexamethasone; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Endotoxemia; Enrofloxacin; Female; Fluoroquinolones; Lipopolysaccharides; Male; Rats; Rats, Sprague-Dawley | 2010 |
Anti-inflammatory effects of insulin regular and flunixin meglumine on endotoxemia experimentally induced by Escherichia coli serotype O55:B5 in an ovine model.
Topics: Animals; Anti-Inflammatory Agents; Clonixin; Disease Models, Animal; Endotoxemia; Escherichia coli Infections; Female; Glutathione Peroxidase; Haptoglobins; Insulin; Interferon-gamma; Serum Amyloid A Protein; Sheep; Tumor Necrosis Factor-alpha | 2013 |
Pharmacokinetics of enrofloxacin and flunixin meglumine and interactions between both drugs after intravenous co-administration in healthy and endotoxaemic rabbits.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Blood Chemical Analysis; Clonixin; Cross-Over Studies; Drug Interactions; Endotoxemia; Enrofloxacin; Fluoroquinolones; Half-Life; Injections, Intravenous; Lipopolysaccharides; Male; Rabbits; Random Allocation | 2008 |
Effect of flunixin meglumine on cytokine levels in experimental endotoxemia in mice.
Topics: Animals; Clonixin; Cytokines; Endotoxemia; Interleukin-10; Interleukin-1beta; Male; Mice; Mice, Inbred BALB C; Prostaglandin Antagonists; Random Allocation; Tumor Necrosis Factor-alpha | 2007 |
Watery mouth disease in lambs: biochemical parameters before and after treatment.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Clavulanic Acids; Clonixin; Drug Therapy, Combination; Endotoxemia; Escherichia coli Infections; Fluid Therapy; Sheep; Sheep Diseases | 1996 |
Survey of diplomates of the American College of Veterinary Internal Medicine and the American College of Veterinary Surgeons regarding clinical aspects and treatment of endotoxemia in horses.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Clonixin; Endotoxemia; Fluid Therapy; Horse Diseases; Horses; Prevalence; Surveys and Questionnaires; United States | 1997 |
Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Clonixin; Disease Models, Animal; Drug Combinations; Endotoxemia; Escherichia coli; Escherichia coli Infections; Hemodynamics; Horse Diseases; Horses; Interleukin-6; Leukocyte Count; Pentoxifylline; Plasminogen Activator Inhibitor 1; Thromboxane B2; Time Factors; Tissue Plasminogen Activator; Tumor Necrosis Factor-alpha; Vasodilator Agents | 1997 |